Peptide Dosage Chart Reference by What Each Label Number Means

A peptide dosage chart is only as useful as the numbers in it, and the biggest source of error is that people read every number on a label as a dose. In fact a label carries several different numbers: strength, dose, concentration and purity. Each answers a different question. This stop on the Bench line organizes the reference by what a number means and where it comes from, using approved drug labels, and it marks every unapproved row as having no established dose.

Four Numbers That Look Alike

Start with the vocabulary, because charts blur it. Strength is the total amount of drug in a container. Concentration is that amount divided by the liquid volume, so a pen holding a given total in three milliliters has a concentration per milliliter. Dose is what the label tells a patient to receive in one injection for a named use. Purity is something else again: as the earlier Bench stop on reading a purity number explains, it describes how much of a powder is the intended peptide, and it is not an amount at all. The earlier stops on this line on freeze-drying and on mixing show where the other three numbers come from, and why each needs its own proof.

These four are linked by arithmetic, but you cannot go backward from one to another without the rest. A strength tells you nothing about dose until you know how many doses the container holds. A concentration tells you nothing until you know the volume. A purity percentage fits neither. Mixing them up is the root of most chart errors, and a chart that lists only one number for a compound is leaving out most of what you need to read it safely. Think of a recipe that gives the weight of the flour in the bag but not the amount for one loaf: the figure is true, and it answers a different question than the one you asked.

A Peptide Dosage Chart Built From Approved Labels

The table below does something unusual: it shows the label field each number comes from. Vyleesi, a single-dose autoinjector, is the simple case, where strength and dose match. Ozempic is a multi-dose pen, so its total strength is far larger than the dose per injection. Zepbound comes in pens, single-dose vials and a multi-dose vial, and its label expresses doses in milligrams but vial users measure liquid in milliliters. Egrifta WR is a powder, where the vial figure is contents and the dose is a different, smaller figure. All four labels come from DailyMed, which hosts the current versions, and each field named in the table is a heading you can find there.

Read these as label examples, not advice, since each applies to one product for one approved use under a prescriber, and labels are revised, so a current copy is the only version that counts. The unapproved rows are as important as the approved ones. For compounds sold as research peptides, a number on a vial is a seller's claim about contents, and no regulator has set a dose. Any peptide dose chart that fills those rows with amounts is not reporting evidence, because there is none. A neat layout can make a guess look official, which is why this table keeps the unapproved rows blank on purpose.

Peptide Dose Chart Claims for Unapproved Compounds

When someone shares a peptide dose chart for an unapproved compound, ask where each figure came from. The usual answers are animal studies, small human reports of a different product, or earlier posts. Animal papers describe amounts per kilogram of a rodent, which are not human instructions, and the studies used careful laboratory preparation that a home setting cannot match. Human reports are rare and use specific products under supervision, so they cannot be copied to a different vial. The honest content of such a chart is a single phrase repeated in every row: no established dose for human use.

That is also why a label number in a search, such as 5 mg or 10 mg, deserves care. It describes what a seller says is in the vial. It does not tell you how many people the vial serves, how much to take or whether the content is true, since vendor vials come without independent testing. A better habit is to ask three questions about any figure: which field is it, who tested it, and in whom. These questions work on every chart, whether it appears in a PDF, a video or a forum thread. If no one can answer, the figure should not guide any decision about your body.

Why Units Cause Real Harm

Mistakes with units are not theoretical, and they have already put people in hospital. In 2024 FDA warned that patients using compounded semaglutide from multi-dose vials had measured and taken five to twenty times the intended dose, and that some provider conversions between milligrams and units or milliliters produced five to ten times the intended amount. The alert noted that doses written in units depend on concentration, that patients used the wrong syringe, and that some sought medical help or were hospitalized. In one pattern, a patient told to draw a small number of units drew ten times as many, because the syringe markings were misread.

Even an approved vial label shows the issue. The Zepbound label states doses in milligrams, while the syringe example it gives measures milliliters, so the user has to convert. A peptide dosage chart that lists only milligrams, or only units, or only milliliters, hides a step where errors enter. For this reason no chart on this site converts a human dose into syringe units, and none gives any amount for an unapproved compound. Ask a pharmacist to check measuring, and use approved pens when your prescriber offers them, because a pen delivers a set dose without any conversion by the user.

Conclusion

The most useful peptide dosage chart separates strength, dose, concentration and purity, and names the label field behind each number. Approved drugs have all four on a label, and unapproved compounds have only a seller's claim, with no established dose. When a chart blurs these, it invites measuring mistakes like those FDA described. Check the number against a current label, ask a pharmacist, and treat any unsourced figure as a guess, not as guidance.